REVB - Revelation Biosciences Inc
IEX Last Trade
1.14
0.130 11.404%
Share volume: 433,667
Last Updated: Fri 30 Aug 2024 09:59:47 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.01
0.13
12.87%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-4.96%
1 Month
-26.28%
3 Months
-30.30%
6 Months
-72.09%
1 Year
-94.45%
2 Year
-90.53%
Key data
Stock price
$1.14
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.81 - $28.20
52 WEEK CHANGE
-$0.94
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website:
Employees: 10
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 10
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
we develop immunologic therapeutics and diagnostics designed to make the world a healthier place
Recent news